Stock A067080 DAE HWA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights DAE HWA Pharmaceutical Co., Ltd.

Equities

A067080

KR7067080002

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-07-02 EDT 		5-day change 1st Jan Change
10,750 KRW +1.22% Intraday chart for DAE HWA Pharmaceutical Co., Ltd. +6.23% +14.61%
2022 DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index CI
2019 Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.
CI
DAE HWA Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 6, 2019, has expired.
CI
DAE HWA Pharmaceutical Co., Ltd. announces an Equity Buyback for 360,000 shares.
CI
DAE HWA Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
DAE HWA Pharmaceutical Co., Ltd. cancelled the acquisition of REDOXBIL CO.,LTD.
CI
DAE HWA Pharmaceutical Co., Ltd. agreed to acquire REDOXBIL CO.,LTD. for KRW 1.1 billion.
CI
Dae Hwa Pharmaceutical Co., Ltd Proposes Dividend
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A067080 Stock
  4. News DAE HWA Pharmaceutical Co., Ltd.
  5. Highlights